Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis

NCT03546816 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

285

Enrollment

INDUSTRY

Sponsor class

Conditions

Pruritus
Prurigo Nodularis

Interventions

DRUG: 5mg Serlopitant Tablets
DRUG: Placebo Tablets

Sponsor

Vyne Therapeutics Inc.